Immunovant, Inc. (IMVT) NASDAQ

26.60

+0.24(+0.91%)

Updated at February 20 04:00PM

Currency In USD

Valuation

Market Cap2.59B
Enterprise Value1.88B
P/E Ratio-10.4
PEG Ratio-1.97
Price/Sales Ratio0
Price/Book Ratio4.9
Enterprise/Revenue0
Enterprise/EBITDA-9.18

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.44
Return On Equity-0.66

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-437.78M
Net Income-413.84M
Diluted EPS-2.73

Balance Sheet

Total Cash994.53M
Total Cash/Share5.48
Total Debt0
Total Debt/Equity0
Current Ratio15.74
Book Value Per Share5.43

Price History

52-Week Change25.06
52-Week High27.92
52-Week Low12.72
Moving Average 50 Days25.77
Moving Average 200 Days19.43

Statistics

Average Volume1.64M
Shares Outstanding203.53M
% Held by Institutions35.94

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A